Monahan B P, Ferguson C L, Killeavy E S, Lloyd B K, Troy J, Cantilena L R
Department of Medicine, National Naval Medical Center, Bethesda, MD.
JAMA. 1990 Dec 5;264(21):2788-90.
Torsades de pointes is a form of polymorphic ventricular tachycardia that is associated with prolongation of the QT interval. Although found in many clinical settings, torsades de pointes is most often drug induced. This report describes the first association (exclusive of drug overdose) of symptomatic torsades de pointes occurring with the use of terfenadine in a patient who was taking the recommended prescribed dose of this drug in addition to cefaclor, ketoconazole, and medroxyprogesterone. Measured serum concentrations of terfenadine and its main metabolite showed excessive levels of parent terfenadine and proportionately reduced concentrations of metabolite, suggesting inhibition of terfenadine metabolism. We believe that a drug interaction between terfenadine and ketoconazole resulted in the elevated terfenadine levels in plasma and in the cardiotoxicity previously seen only in cases of terfenadine overdose.
尖端扭转型室速是一种多形性室性心动过速,与QT间期延长有关。尽管在许多临床情况下都可发现,但尖端扭转型室速最常见的原因是药物诱发。本报告描述了首例(不包括药物过量)在使用特非那定的患者中发生有症状的尖端扭转型室速的关联,该患者除服用头孢克洛、酮康唑和甲羟孕酮外,还按推荐剂量服用了该药。所测血清特非那定及其主要代谢物浓度显示,母体特非那定水平过高,代谢物浓度相应降低,提示特非那定代谢受到抑制。我们认为,特非那定与酮康唑之间的药物相互作用导致血浆中特非那定水平升高,并引发了此前仅在特非那定过量病例中出现的心脏毒性。